3,4-dihydroisoquinoline-2(1H)-carbothioamide, 95.0%, 10g

N-Benzyl-4-bromo-3-methylbenzamide, 95.0%, 250mg

2-((tert-Butoxycarbonyl)amino)ethyl 4-methylbenzenesulfonate, 95.0%, 5g

2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isothiazolidine 1,1-dioxide, 97%, 250mg

ROTI®Cell RPMI-1640

2-methyl-5-(3-methyl-5-isoxazolyl)-3-thiophenesulfonyl chloride, 95.0%, 1g

Naphthalen-1-yl propionate, 95+%, 5g

(6-Chloropyrazin-2-yl)acetic acid, 95.0%, 5g

5,5'-Dibromo-4,4'-dihexyl-2,2'-bithiophene>95.0%(GC)1g

1,2-Dichloro-3-fluoro-4-iodobenzene, 97.0%, 1g

1-((2S,3S,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98%, 5mg

4-(Methylsulfonyl)piperidine hydrochloride, 95.0%, 5g

6-(3-methoxyphenyl)-3-nitro-2-pyridinamine, 95.0%, 1g